Literature DB >> 16958599

Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time.

Ina H Benoy1, Hilde Elst, Peter Van Dam, Simon Scharpé, Eric Van Marck, Peter B Vermeulen, Luc Y Dirix.   

Abstract

BACKGROUND: We and others have recently explored the use of quantitative real-time RT-PCR analysis for the detection of circulating tumour cells in blood of patients with breast cancer (BC). One major problem in these experiments is the in vitro instability of the cellular RNA. The copy number of mRNA can change during storage and transport at room temperature and this may hamper accurate quantitative measurements of specific transcripts, especially when working with small numbers of target mRNAs.
METHODS: Peripheral blood samples were obtained from two healthy volunteers and 13 patients with BC. Blood was stored at room temperature for 0, 1, 2, 4, 6, 24, 48 and 72 h. The potential alteration of gene expression for six target genes was investigated by quantitative real-time RT-PCR.
RESULTS: For beta-actin, GAPDH, cytokeratin-19 (CK-19) and HER2, a significant decrease in expression level occurs after 4 h (CK-19 and HER2), 6 h (beta-actin) or 24 h (GAPDH). Mammaglobin expression was only measurable in two samples and seems to be stable for at least 6 h. For vascular endothelial growth factor (VEGF), a statistically significant increase in expression level is observed in samples processed 24 h after collection.
CONCLUSIONS: Most transcripts were reduced in samples that were stored overnight at room temperature compared with fresh samples, but upregulation of transcripts, probably as an active response to cellular stress, also occurs when blood is removed from its in vivo environment and stored ex vivo. Optimally, blood samples and RNA should be processed or stabilised within 3 h after collection to avoid interference of the in vivo gene expression signature by ex vivo stress responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958599     DOI: 10.1515/CCLM.2006.210

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

Review 1.  Biobanking in genomic medicine.

Authors:  Jane H Zhou; Aysegul A Sahin; Jeffrey N Myers
Journal:  Arch Pathol Lab Med       Date:  2015-06       Impact factor: 5.534

Review 2.  The current status of the clinical utility of liquid biopsies in cancer.

Authors:  Anson Snow; Denaly Chen; Julie E Lang
Journal:  Expert Rev Mol Diagn       Date:  2019-09-08       Impact factor: 5.225

3.  Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

Authors:  Monica M Reinholz; Kathleen A Kitzmann; Kathleen Tenner; David Hillman; Amylou C Dueck; Timothy J Hobday; Donald W Northfelt; Alvaro Moreno-Aspitia; Vivek Roy; Betsy LaPlant; Jake B Allred; Philip J Stella; Wilma L Lingle; Edith A Perez
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

4.  Vascular endothelial growth factor expression in rat skin incision wound.

Authors:  Makoto Nogami; Tomoaki Hoshi; Mayumi Kinoshita; Tomomi Arai; Michiho Takama; Ichiro Takahashi
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

5.  Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks.

Authors:  Daniel Gilbert Weber; Swaantje Casjens; Peter Rozynek; Martin Lehnert; Sandra Zilch-Schöneweis; Oleksandr Bryk; Dirk Taeger; Maria Gomolka; Michaela Kreuzer; Heinz Otten; Beate Pesch; Georg Johnen; Thomas Brüning
Journal:  Biomark Insights       Date:  2010-09-22

Review 6.  Human mammaglobin in breast cancer: a brief review of its clinical utility.

Authors:  Fawwaz Shakir Al Joudi
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

7.  Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.

Authors:  Ciputra Adijaya Hartana; Johan Kinn; Robert Rosenblatt; Stefan Anania; Farhood Alamdari; Hans Glise; Amir Sherif; Ola Winqvist
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

8.  Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells.

Authors:  Keith H K Wong; Shannon N Tessier; David T Miyamoto; Kathleen L Miller; Lauren D Bookstaver; Thomas R Carey; Cleo J Stannard; Vishal Thapar; Eric C Tai; Kevin D Vo; Erin S Emmons; Haley M Pleskow; Rebecca D Sandlin; Lecia V Sequist; David T Ting; Daniel A Haber; Shyamala Maheswaran; Shannon L Stott; Mehmet Toner
Journal:  Nat Commun       Date:  2017-11-23       Impact factor: 14.919

9.  Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay.

Authors:  Suzy E Meijer; Olga Klebanov-Akopyn; Vera Pavlov; Shachar Laks; David Hazzan; Aviram Nissan; Douglas Zippel
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-11-16

10.  Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.

Authors:  Fikret Rifatbegovic; M Reza Abbasi; Sabine Taschner-Mandl; Maximilian Kauer; Andreas Weinhäusel; Rupert Handgretinger; Peter F Ambros
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.